Stockscreener 앱 받기
2.61
0.77%
0.02
시간 외 거래:
2.60
-0.010
-0.38%
전일 마감가:
$2.59
열려 있는:
$2.64
하루 거래량:
4.64M
Relative Volume:
0.45
시가총액:
$191.90M
수익:
-
순이익/손실:
$-22.83M
주가수익비율:
-3.3038
EPS:
-0.79
순현금흐름:
$-20.87M
1주 성능:
+7.41%
1개월 성능:
+264.53%
6개월 성능:
+505.57%
1년 성능:
+328.92%
1일 변동 폭
$2.41
$2.67
1주일 범위
$2.26
$2.67
52주 변동 폭
$0.2223
$3.83
Cognition Therapeutics Inc Stock (CGTX) Company Profile
명칭
Cognition Therapeutics Inc
전화
412-481-2210
주소
2403 SIDNEY STREET, PITTSBURGH
CGTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGTX
Cognition Therapeutics Inc
|
2.61 | 228.50M | 0 | -22.83M | -20.87M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-19 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2024-07-30 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-11-03 | 개시 | B. Riley Securities | Buy |
| 2021-11-03 | 개시 | Oppenheimer | Outperform |
Cognition Therapeutics Inc 주식(CGTX)의 최신 뉴스
Visualizing Cognition Therapeutics Inc. stock with heatmapsPortfolio Growth Summary & Community Supported Trade Ideas - Newser
Cognition Therapeutics Regains Nasdaq Compliance - MSN
Cognition Therapeutics Inc. stock retracement – recovery analysisInsider Buying & Daily Stock Trend Watchlist - Newser
Is Cognition Therapeutics Inc. Forming a Bottom PatternMarket Sentiment Review & Weekly Momentum Stock Picks - beatles.ru
Chart overlay techniques for tracking Cognition Therapeutics Inc.2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Cognition Therapeutics Inc. stock prediction for this weekTreasury Yields & Daily Chart Pattern Signal Reports - Newser
Tick level data insight on Cognition Therapeutics Inc. volatilityMarket Trend Report & Fast Moving Stock Trade Plans - Newser
Can Cognition Therapeutics Inc. keep up with sector leaders2025 Bull vs Bear & Free Community Consensus Stock Picks - خودرو بانک
Neurology biopharmas rebound on trial catalysts and Q2 gains - BioWorld MedTech
What moving averages say about Cognition Therapeutics Inc.2025 Retail Activity & High Yield Stock Recommendations - Newser
Is Cognition Therapeutics Inc. a stock for growth or value investors2025 Price Targets & Low Drawdown Trading Strategies - خودرو بانک
Backtesting results for Cognition Therapeutics Inc. trading strategiesMarket Risk Report & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-05 00:35:53 - Newser
Published on: 2025-09-05 00:14:17 - Newser
Real time pattern detection on Cognition Therapeutics Inc. stockRisk Management & Advanced Technical Signal Analysis - Newser
Support Zone Holds Steady for Cognition Therapeutics Inc. After DipMarket Weekly Review & Weekly High Conviction Ideas - Newser
Multi asset correlation models including Cognition Therapeutics Inc.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser
Cognition Therapeutics Inc. stock trend forecastTrade Entry Summary & Breakout Confirmation Trade Signals - Newser
Top chart patterns to watch in Cognition Therapeutics Inc.Weekly Trend Report & Safe Capital Growth Plans - Newser
How to manage a losing position in Cognition Therapeutics Inc.Earnings Overview Report & Low Risk High Win Rate Picks - Newser
Can Cognition Therapeutics Inc. recover in the next quarter2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
How sentiment analysis helps forecast Cognition Therapeutics Inc.Quarterly Growth Report & Daily Entry Point Alerts - Newser
Real time scanner hits for Cognition Therapeutics Inc. explainedTreasury Yields & Community Verified Swing Trade Signals - Newser
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone By Investing.com - Investing.com South Africa
Cognition Therapeutics closes $30 million registered direct offering By Investing.com - Investing.com Australia
Does Cognition Therapeutics Inc. have pricing power2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - khodrobank.com
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone - Investing.com
Trend analysis for Cognition Therapeutics Inc. this weekPortfolio Update Summary & AI Powered Trade Plan Recommendations - Newser
Cognition Therapeutics, Inc. Achieves 75% Enrollment in Phase 2 START Study for Early Alzheimer’s Disease Treatment - Quiver Quantitative
Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target - GlobeNewswire
540-Patient Alzheimer's Trial: Cognition's Once-Daily Oral Drug Zervimesine Reaches Major Milestone - Stock Titan
What’s next for Cognition Therapeutics Inc. stock price2025 Performance Recap & Growth-Oriented Investment Plans - Newser
MACD Cross Could Confirm Trend in Cognition Therapeutics Inc.Weekly Market Summary & AI Enhanced Trading Alerts - beatles.ru
Cognition Therapeutics shares fall 1.23% premarket after closing a $30 million registered direct offering. - AInvest
How to integrate Cognition Therapeutics Inc. into portfolio analysis toolsJuly 2025 Decliners & Advanced Technical Analysis Signals - Newser
Is Cognition Therapeutics Inc. still worth holding after the dipGold Moves & Free Safe Capital Growth Stock Tips - Newser
Cognition Therapeutics Inc. stock trend outlook and recovery pathTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
Will Cognition Therapeutics Inc. stock go up soonJuly 2025 Momentum & Short-Term Swing Trade Alerts - Newser
How to build a custom watchlist for Cognition Therapeutics Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
What to expect from Cognition Therapeutics Inc. in the next 30 daysWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - Newser
Automated trading signals detected on Cognition Therapeutics Inc.Take Profit & Expert Curated Trade Setup Alerts - Newser
Is Cognition Therapeutics Inc. trading at a discountJuly 2025 Trends & Smart Money Movement Alerts - خودرو بانک
Cognition Therapeutics Closes $30 Million Direct Offering - MarketScreener
Cognition Therapeutics closes $30 million registered direct offering - Investing.com
$30 Million Funding: Cognition Therapeutics Advances Breakthrough Neurodegenerative Drug to Phase 3 - Stock Titan
Cognition Therapeutics Inc (CGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):